TIPIRACIL\TRIFLURIDINE: 10,250 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
10,250
Total FAERS Reports
4,127 (40.3%)
Deaths Reported
2,862
Hospitalizations
10,250
As Primary/Secondary Suspect
119
Life-Threatening
45
Disabilities
Active Ingredient: TIPIRACIL HYDROCHLORIDE\TRIFLURIDINE ·
First Report: 20041106 · Latest Report: 20250908
What Are the Most Common TIPIRACIL\TRIFLURIDINE Side Effects?
#1 Most Reported
Death
3,017 reports (29.4%)
#2 Most Reported
Disease progression
1,774 reports (17.3%)
#3 Most Reported
Fatigue
1,298 reports (12.7%)
All TIPIRACIL\TRIFLURIDINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 3,017 | 29.4% | 3,013 | 197 |
| Disease progression | 1,774 | 17.3% | 831 | 388 |
| Fatigue | 1,298 | 12.7% | 197 | 335 |
| Nausea | 1,135 | 11.1% | 172 | 335 |
| Diarrhoea | 965 | 9.4% | 111 | 321 |
| Decreased appetite | 659 | 6.4% | 105 | 216 |
| Vomiting | 628 | 6.1% | 93 | 277 |
| White blood cell count decreased | 483 | 4.7% | 49 | 202 |
| Asthenia | 472 | 4.6% | 104 | 228 |
| Anaemia | 388 | 3.8% | 76 | 183 |
| Neutropenia | 370 | 3.6% | 53 | 127 |
| Drug ineffective | 361 | 3.5% | 33 | 41 |
| Constipation | 322 | 3.1% | 42 | 115 |
| Dehydration | 318 | 3.1% | 41 | 249 |
| Abdominal pain | 313 | 3.1% | 43 | 134 |
| Weight decreased | 302 | 3.0% | 58 | 124 |
| Inappropriate schedule of product administration | 280 | 2.7% | 109 | 72 |
| Off label use | 268 | 2.6% | 114 | 77 |
| Malaise | 247 | 2.4% | 49 | 119 |
| Pain | 240 | 2.3% | 52 | 126 |
Who Reports TIPIRACIL\TRIFLURIDINE Side Effects? Age & Gender Data
Gender: 42.8% female, 57.2% male. Average age: 64.0 years. Most reports from: US. View detailed demographics →
Is TIPIRACIL\TRIFLURIDINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2004 | 1 | 0 | 0 |
| 2012 | 3 | 1 | 0 |
| 2014 | 7 | 2 | 4 |
| 2015 | 133 | 70 | 53 |
| 2016 | 1,417 | 403 | 321 |
| 2017 | 1,189 | 333 | 325 |
| 2018 | 990 | 350 | 282 |
| 2019 | 741 | 419 | 277 |
| 2020 | 685 | 407 | 219 |
| 2021 | 651 | 377 | 194 |
| 2022 | 495 | 329 | 124 |
| 2023 | 481 | 289 | 124 |
| 2024 | 298 | 149 | 106 |
| 2025 | 142 | 37 | 69 |
What Is TIPIRACIL\TRIFLURIDINE Used For?
| Indication | Reports |
|---|---|
| Colon cancer | 4,053 |
| Colorectal cancer metastatic | 1,320 |
| Rectal cancer | 1,297 |
| Product used for unknown indication | 811 |
| Colorectal cancer | 404 |
| Colon cancer metastatic | 370 |
| Rectosigmoid cancer | 263 |
| Gastric cancer | 171 |
| Neoplasm malignant | 147 |
| Adenocarcinoma of colon | 135 |
TIPIRACIL\TRIFLURIDINE vs Alternatives: Which Is Safer?
TIPIRACIL\TRIFLURIDINE vs TIPRANAVIR
TIPIRACIL\TRIFLURIDINE vs TIRAGOLUMAB
TIPIRACIL\TRIFLURIDINE vs TIRBANIBULIN
TIPIRACIL\TRIFLURIDINE vs TIROFIBAN
TIPIRACIL\TRIFLURIDINE vs TIRZEPATIDE
TIPIRACIL\TRIFLURIDINE vs TISAGENLECLEUCEL
TIPIRACIL\TRIFLURIDINE vs TISLELIZUMAB
TIPIRACIL\TRIFLURIDINE vs TISOTUMAB VEDOTIN
TIPIRACIL\TRIFLURIDINE vs TISOTUMAB VEDOTIN-TFTV
TIPIRACIL\TRIFLURIDINE vs TITANIUM DIOXIDE\ZINC
Official FDA Label for TIPIRACIL\TRIFLURIDINE
Official prescribing information from the FDA-approved drug label.